Credit Suisse’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$3.32M Sell
100,544
-10,289
-9% -$321K ﹤0.01% 1542
2023
Q4
$3.02M Sell
110,833
-13,734
-11% -$341K ﹤0.01% 1642
2023
Q3
$3M Buy
124,567
+28,522
+30% +$765K ﹤0.01% 1578
2023
Q2
$3.07M Buy
96,045
+17,974
+23% +$583K ﹤0.01% 1657
2023
Q1
$2.39M Buy
78,071
+3,805
+5% +$150K ﹤0.01% 1760
2022
Q4
$2.9M Buy
74,266
+16,398
+28% +$734K ﹤0.01% 1659
2022
Q3
$2.76M Buy
57,868
+3,725
+7% +$212K ﹤0.01% 1640
2022
Q2
$2.1M Buy
54,143
+8,919
+20% +$355K ﹤0.01% 1877
2022
Q1
$2.59M Sell
45,224
-9,149
-17% -$600K ﹤0.01% 1908
2021
Q4
$4.33M Sell
54,373
-145,610
-73% -$12.5M ﹤0.01% 2133
2021
Q3
$17.4M Buy
199,983
+171,014
+590% +$17.2M 0.01% 1159
2021
Q2
$3.73M Buy
28,969
+5,168
+22% +$412K ﹤0.01% 2337
2021
Q1
$1.91M Sell
23,801
-34,927
-59% -$3.32M ﹤0.01% 2859
2020
Q4
$4.79M Buy
58,728
+49,907
+566% +$2.45M ﹤0.01% 2120
2020
Q3
$218K Buy
+8,821
New +$219K ﹤0.01% 3806

Other funds holding BEAM